Genomics

Dataset Information

0

Identification of miRNAs enriched in Extracellular vesicles derived from serum samples of breast cancer patients


ABSTRACT: Purpose: In this study, we performed RNA-seq analysis as a screening strategy to identify EV-miRNAs derived from serum of well clinically annotated breast cancer (BC) patients from South of Brazil. Methods: EVs from three groups of samples, healthy controls (CT), luminal A (LA), and triple negative (TNBC), were isolated from serum using a precipitation method and analyzed by RNA-seq (screening phase). Subsequently, four EV-miRNAs (miR-142-5p, miR-150-5p, miR-320a, and miR-4433b-5p) were selected to be quantified by RT-qPCR in individual samples (test phase). Results: A panel composed of miR-142-5p, miR-320a, and miR-4433b-5p discriminated BC patients from CT with an AUC of 0.8387 (93.33% sensitivity, 68.75% specificity). In addition, the combination of miR-142-5p and miR-320a, presented an AUC of 0.941 (100% sensitivity, 93.80% specificity) in distinguishing LA patients from CT. Interestingly, decrease expression of miR-142-5p and miR-150-5p were significantly associated with more advanced tumor grades (grade III), while the decrease expression of miR-142-5p and miR-320a with larger tumor size. Conclusion: These results provide insights into the potential application of EVs-miRNAs from serum as novel specific markers for early diagnosis of BC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE141326 | GEO | 2020/03/16

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2023-01-13 | ST002446 | MetabolomicsWorkbench
2022-02-26 | E-MTAB-11160 | biostudies-arrayexpress
2015-12-20 | E-GEOD-59418 | biostudies-arrayexpress
2024-01-31 | GSE254285 | GEO
2015-12-20 | GSE59418 | GEO
2024-03-25 | GSE261798 | GEO
2024-07-28 | GSE207715 | GEO
2016-12-31 | GSE70318 | GEO
2022-11-01 | GSE216794 | GEO
2014-06-27 | GSE58849 | GEO